Evidence map›Paper›PMID 38006459›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2024

Identification of Novel -Glucosidase Inhibitors from Syzygium jambos (L.) Using Spectroscopy and Molecular Docking.

Yao Jiang, Feifei Liu, Dan Zhang, Xiujuan Fu, Siwei Chen, Mei Wei, Zhi Li, Hui Lei, Hong Niu

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yao Jiang *School of Pharmacy, Southwest Medical University, Luzhou, 646000, China.
Feifei Liu *School of Life Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu, China.
Dan ZhangSchool of Pharmacy, Southwest Medical University, Luzhou, 646000, China.
Xiujuan FuSchool of Pharmacy, Southwest Medical University, Luzhou, 646000, China.
Siwei ChenSchool of Pharmacy, Southwest Medical University, Luzhou, 646000, China.
Mei WeiThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, 646000, China.
Zhi LiThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, 646000, China. lizhi-swmu@126.com.
Hui LeiSchool of Pharmacy, Southwest Medical University, Luzhou, 646000, China. huilei@swmu.edu.cn.
Hong NiuSchool of Pharmacy, Southwest Medical University, Luzhou, 646000, China. dawn123454@swmu.edu.cn.
Southwest Medical University · CNJiangsu Normal University · CN

Funding

Department of Science and Technology of Sichuan Province (2022NSFSC0109)National Natural Science Foundation of China (No. 31900293)Sichuan Science and Technology Program (2022YFS0624)Sichuan Traditional Chinese Medicine Administration. (2023zd008)
6 · The paper itself

Abstract

Fruits of Syzygium jambos (L.) are recognized as a "food", exhibiting significant antidiabetic activities. However, the α-glucosidase inhibition of the components from Syzygium jambos (L.) have not yet been investigated. In this study, a total of 14 compounds were isolated from Syzygium jambos (L.) Alston, eight of which showed significant inhibitory effects on α-glucosidase, with IC

Indexed as

Syzygiumalpha-GlucosidasesEnzyme InhibitorsGlycoside Hydrolase InhibitorsKineticsMolecular Docking SimulationSpectrum Analysisalpha-GlucosidasesEnzyme InhibitorsGlycoside Hydrolase InhibitorsAlkylphenol derivativesMolecular dockingSyzygium jambos (L.) Alston fruitType 2 diabetesα-glucosidase inhibition

Identifiers

PMID38006459
OpenAlexW4389000602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.